A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Silo Pharma, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,373 shares of SILO stock, worth $13,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,373
Holding current value
$13,654
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.86 - $3.47 $12,360 - $49,874
14,373 New
14,373 $15,000

Others Institutions Holding SILO

About Silo Pharma, Inc.


  • Ticker SILO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,137,910
  • Market Cap $2.98M
  • Description
  • Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...
More about SILO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.